Its like a processing hub for energy-balance control. Because of its short lifespan, its unlikely that natural GLP-1 produced in the intestines reaches high enough concentrations in the brain to affect satiety
The practical implication is that you should view semaglutide as a long-term commitment rather than a short-term intervention
Researchers have noted its potential to repair various musculoskeletal injuries, including fractures, tendon ruptures, and muscle tears
A., Morrison, J., Berg, R
Tirzepatide, a dual GIP/GLP-1 agonist, produces somewhat larger weight reductions in clinical trialsaveraging 22% versus 15% for semaglutidewhich might translate to slightly greater blood pressure benefits in individual patients